| Last Price$28.96 | Day Change (%)-0.99% |
| Open Price$29.21 | Day Change ($)-0.29 |
| Day Range28.83–29.37 | 52-Week Range21.40–31.15 |
As of Fri 05/17/2013 07:09 PM EDT | USD
Good day, everyone and welcome to Pfizer's First Quarter 2013 Earnings Conference Call. Today's call is being recorded.
Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation
Pain Therapeutics: Pfizer Reassessing Continued Remoxy Partnership
UPDATE: Drug Firms Stalk Actavis Deal
UPDATE: Drug Firms Stalk Actavis Deal
Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years
Pfizer 1st-Quarter Profit Up 53% on One-Time Gains; Cuts 2013 Outlook
Tech Council of Maryland Announces Winners of 2013 Tech Awards at Annual Dinner and Celebration
Novartis Considers Possible Bid for Actavis
PULSE: Pfizer arthritis drug doesn't get European nod